Current Neuro-Oncology
Volume
25 Number 22
30 November 2023
Home > Publications > Current Neuro-Oncology > Volume 25, Year 2023 > Number 22, 30 november
Zhu Q, Jiang H, Cui Y, Ren X, Li M,
Zhang X, Li H, Shen S, Li M, Lin S.
Intratumoral
calcification: not only a diagnostic but also a prognostic
indicator in oligodendrogliomas.
Eur
Radiol. 2023 Nov 16∟.
doi: 10.1007/s00330-023-10405-9∟.
PMID: 37968476∟.
Observational study˰ ˍ
Inoue T, Endo T, Muto J, Umebayashi
D, Mitsuhara T, Shigekawa S, Kanematsu R, Iwasaki M, Takami T,
Hida K, Mizuno M; Investigators of Intramedullary Spinal Cord
Tumors in the Neurospinal Society of Japan.
Shorter
survival time of adolescents and young adult patients than older
adults with spinal cord glioblastoma: a multicenter study.
J
Neurosurg Spine. 2023 Nov 17:1-10∟.
doi: 10.3171/2023.9.SPINE23642∟.
PMID: 37976504∟.
Observational study˰ ˍ
Haas-Kogan DA, Aboian MS, Minturn
JE, Leary SES, Abdelbaki MS, Goldman S, Elster JD, Kraya A, Lueder
MR, Ramakrishnan D, von Reppert M, Liu KX, Rokita JL, Resnick AC,
Solomon DA, Phillips JJ, Prados M, Molinaro AM, Waszak SM, Mueller
S.
Everolimus
for Children With Recurrent or Progressive Low-Grade Glioma:
Results From the Phase II PNOC001 Trial.
J
Clin Oncol. 2023 Nov 17:JCO2301838∟.
doi: 10.1200/JCO.23.01838∟.
PMID: 37978951∟.
Interventional study. ˍ
Kilburn LB, Khuong-Quang DA,
Hansford JR, Landi D, van der Lugt J, Leary SES, Driever PH,
Bailey S, Perreault S, McCowage G, Waanders AJ, Ziegler DS, Witt
O, Baxter PA, Kang HJ, Hassall TE, Han JW, Hargrave D, Franson AT,
Yalon Oren M, Toledano H, Larouche V, Kline C, Abdelbaki MS,
Jabado N, Gottardo NG, Gerber NU, Whipple NS, Segal D, Chi SN,
Oren L, Tan EEK, Mueller S, Cornelio I, McLeod L, Zhao X, Walter
A, Da Costa D, Manley P, Blackman SC, Packer RJ, Nysom K.
The
type II RAF inhibitor tovorafenib in relapsed/refractory pediatric
low-grade glioma: the phase 2 FIREFLY-1 trial.
Nat
Med. 2023 Nov 17∟.
doi: 10.1038/s41591-023-02668-y∟.
PMID: 37978284∟.
Interventional study. ˍ
Gregucci F, Di Guglielmo FC, Surgo
A, Carbonara R, Laera L, Ciliberti MP, Gentile MA, Calbi R,
Caliandro M, Sasso N, Davi' V, Bonaparte I, Fanelli V, Giraldi D,
Tortora R, Internò V, Giuliani F, Surico G, Signorelli F,
Lombardi G, Fiorentino A.
Reirradiation
with radiosurgery or stereotactic fractionated radiotherapy in
association with regorafenib in recurrent
glioblastoma.
Strahlenther
Onkol. 2023 Nov 21∟.
doi: 10.1007/s00066-023-02172-9∟.
PMID: 37987802∟.
Observational study˰ ˍ
Zhang H, Jiang X, Ren F, Gu Q, Yao
J, Wang X, Zou S, Gan Y, Gu J, Xu Y, Wang Z, Liu S, Wang X, Wei
B.
Development
and external validation of dual online tools for prognostic
assessment in elderly patients with high-grade glioma: a
comprehensive study using SEER and Chinese cohorts.
Front
Endocrinol (Lausanne). 2023 Nov 21;14:1307256∟.
doi: 10.3389/fendo.2023.1307256∟.
PMID: 38075045∟.
Observational study. ˍ
Zhong S, Fu X, Wu C, Liu R, Li
S.
Leptomeningeal
spread in high-grade gliomas: Is surgery or adjuvant therapy after
leptomeningeal spread associated with survival benefit?
Neurosurg
Rev. 2023 Nov 23;46(1):311∟.
doi: 10.1007/s10143-023-02209-8∟.
PMID: 37993665∟.
Observational study. ˍ
*
Mikobi EK, Voorhees G, Mahmood A,
Gandhi A, Bailey M, Phillips J.
Influence
of Tumor-Treating Fields in a Young Patient With Primary Spinal
Glioblastoma Multiforme (GBM): A Case Report of a Rare
Tumor.
Cureus.
2023 Nov 26;15(11):e49441∟.
doi: 10.7759/cureus.49441∟.
PMID: 38149153∟.
Case report. ˍ
Kassotis AS, Garcia MDL, Sun Y,
Mbekeani JN, Kazim M.
Clinically
Aggressive Low-Grade Optic Nerve Glioma in an Adult Treated With
Selumetinib.
J
Neuroophthalmol. 2023 Nov 27∟.
doi: 10.1097/WNO.0000000000002023∟.
PMID: 38015651∟.
Case report˰ ˍ
Kleinberg L, Ye X, Supko J, Stevens
GHJ, Shu HK, Mikkelsen T, Lieberman F, Lesser GJ, Lee E, Grossman
SA.
A
multi-site phase I trial of Veliparib with standard radiation and
temozolomide in patients with newly diagnosed glioblastoma
multiforme (GBM).
J
Neurooncol. 2023 Nov 28∟.
doi: 10.1007/s11060-023-04514-0∟.
PMID: 38015376∟.
Interventional study˰ ˍ
Sienna J, Kahalley LS, Mabbott D,
Grosshans D, Santiago AT, Paulino ADC, Merchant TE, Manzar GS,
Dama H, Hodgson DC, Chintagumpala M, Okcu MF, Whitehead WE,
Laperriere N, Ramaswamy V, Bartels U, Tabori U, Bennett JM, Das A,
Craig T, Tsang DS.
Proton
Therapy Mediates Dose Reductions to Brain Structures Associated
with Cognition in Children with Medulloblastoma.
Int
J Radiat Oncol Biol Phys. 2023 Nov 29:S0360-3016(23)08164-6∟.
doi: 10.1016/j.ijrobp.2023.11.035∟.
PMID: 38040059∟.
Observational study˰ ˍ
Ahn WK, Hahn SM, Yoon HI, Lee J,
Park EK, Shim KW, Kim DS, Suh CO, Kim SH, Lyu CJ, Han
JW.
Long-term
Outcomes of Protocol-based Treatment for Newly Diagnosed
Medulloblastoma.
Cancer
Res Treat. 2023 Nov 30∟.
doi: 10.4143/crt.2023.865∟.
PMID: 38037318∟.
Observational study. ˍ
*
Baumgarten P, Prange G, Kamp MA,
Monden D, Neef V, Schwarzer F, Dubinski D, Dinc N, Weber KJ,
Czabanka M, Hattingen E, Ronellenfitsch MW, Steinbach JP, Senft
C.
Treatment
of very elderly glioblastoma patients ≥ 75 years
of age: whom to treat.
J
Neurooncol. 2023 Nov 30∟.
doi: 10.1007/s11060-023-04518-w∟.
PMID: 38032426∟.
Observational study. ˍ